ISSN: 1300-7777 E-ISSN: 1308-5263
Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy [Turk J Hematol]
Turk J Hematol. 2018; 35(2): 135-136 | DOI: 10.4274/tjh.2017.0448  

Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy

Takashi Onaka1, Tomoya Kitagawa1, Chika Kawakami2, Akihito Yonezawa1
1Kokura Memorial Hospital, Clinic of Hematology, Kitakyushu, Fukuoka, Japan
2University of Occupational and Environmental, Department of Dermatology, Fukuoka, Japan

Keywords: Brentuximab vedotin, Cutaneous ALCL


Kutanöz Anaplastik Büyük Hücreli Lenfomada Brentuksimab Vedotin Monoterapisi ile Düzelme

Takashi Onaka1, Tomoya Kitagawa1, Chika Kawakami2, Akihito Yonezawa1
1Kokura Memorial Hospital, Clinic of Hematology, Kitakyushu, Fukuoka, Japan
2University of Occupational and Environmental, Department of Dermatology, Fukuoka, Japan

Anahtar Kelimeler: Brentuksimab vetodin, Kutanöz ABHL


Takashi Onaka, Tomoya Kitagawa, Chika Kawakami, Akihito Yonezawa. Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy. Turk J Hematol. 2018; 35(2): 135-136

Corresponding Author: Takashi Onaka, Japan


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2016) = 0.686